As the Department of Health and Human Services prepares to end the COVID-19 public health emergency on May 11, AHA today recommended the agency take immediate actions to help ensure care remains available to patients when and where they need it; support the health care workforce as they continue to shoulder a disproportionate amount of strain; and remove unnecessary administrative and regulatory burdens that prevent providers from modernizing care delivery while adding cost and friction in the health care system.
 
“The recent decision to sunset the COVID-19 public health emergency (PHE) is a testament to the progress we have made; however, as we prepare for that transition, we should not revert to care delivery as it was prior to the pandemic,” the letter states. “Instead let us build on the lessons we have learned and the advancements in care delivery and access we have made. Let us use this crisis to create a more effective, equitable, patient-focused and stable health care system.” 
 
Specifically, AHA recommends HHS make permanent many PHE policies that enabled hospitals and health care systems to deliver care more effectively and efficiently; ensure the Medicaid redetermination process protects coverage and care for vulnerable individuals; revise certain hospital Conditions of Participation and HHS emergency preparedness plans so hospitals and health systems can innovate in ways that improve health care quality and access and adequately prepare for the next national emergency.

Related News Articles

Headline
The Senate Appropriations Committee July 31 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services,…
Headline
The AHA’s Next Generation Leaders Fellowship July 29 announced its 36 fellows for the class of 2026, who will each work with mentors to address a specific…
Headline
The Centers for Medicare & Medicaid Services July 17 issued two letters to states regarding policies on continuous eligibility and workforce initiatives.…
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
The House Energy and Commerce Subcommittee on Health today held a hearing to discuss legislative proposals on health care, including two AHA-supported bills…
Headline
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…